Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[VHL gene and TSC 2 gene]

O Hino1

  • 1Dept. of Experimental Pathology, Cancer Institute.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|October 6, 1997
PubMed
Summary
This summary is machine-generated.

Hereditary cancer studies reveal key genes like von Hippel-Lindau (VHL) and tuberous sclerosis 2 (TSC 2). These findings advance our understanding of cancer development in both inherited and common tumor forms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes for luminal HER2-negative breast cancer cases.

British journal of cancer·2014
Same author

Mesothelin gene expression and promoter methylation/hypomethylation in gynecological tumors.

European journal of gynaecological oncology·2010
Same author

The G1556S-type tuberin variant suppresses tumor formation in tuberous sclerosis 2 mutant (Eker) rats despite its deficiency in mTOR inhibition.

Oncogene·2008
Same author

Interaction of folliculin (Birt-Hogg-Dubé gene product) with a novel Fnip1-like (FnipL/Fnip2) protein.

Oncogene·2008
Same author

Birt-Hogg-Dubé gene mutations in human endometrial carcinomas with microsatellite instability.

The Journal of pathology·2006
Same author

Transgenic rescue from embryonic lethality and renal carcinogenesis in the Nihon rat model by introduction of a wild-type Bhd gene.

Oncogene·2005

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Hereditary cancers, though rare, provide crucial insights into carcinogenesis.
  • Studying inherited cancer syndromes has led to the identification of critical cancer genes.
  • These identified genes are often implicated in sporadic tumor development.

Purpose of the Study:

  • To review the von Hippel-Lindau (VHL) gene in the context of hereditary cancer.
  • To review the tuberous sclerosis 2 (TSC 2) gene in the context of hereditary cancer.
  • To highlight the role of these genes in both hereditary and sporadic cancers.

Main Methods:

  • Literature review of genetic studies on hereditary cancer syndromes.
  • Focus on the von Hippel-Lindau (VHL) disease gene.

Related Experiment Videos

  • Focus on the tuberous sclerosis 2 (TSC 2) gene.

    • Main Results:

    • The VHL gene is a key player in certain hereditary cancer syndromes.
    • The TSC 2 gene is associated with hereditary tumor predisposition.
    • Both VHL and TSC 2 genes have been linked to sporadic tumor development.

    Conclusions:

    • The study of hereditary cancers, exemplified by VHL and TSC 2, is vital for understanding general carcinogenesis.
    • Identified hereditary cancer genes offer insights into the molecular basis of common sporadic tumors.
    • Further research into these genes can inform therapeutic strategies for a broader range of cancers.